# Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome

> **NCT05158439** · PHASE1 · WITHDRAWN · sponsor: **The Foundation for Orthopaedics and Regenerative Medicine**

## Conditions studied

- Tourette Syndrome

## Interventions

- **BIOLOGICAL:** AlloRx

## Key facts

- **NCT ID:** NCT05158439
- **Lead sponsor:** The Foundation for Orthopaedics and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** covid-19
- **Last updated:** 2022-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05158439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05158439, "Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Tourette Syndrome". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05158439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*